{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7552,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de076-b731-71da-a78f-007719e300bb",
      "docSlug": "1616e8b22ac58e7f024f1153201d610f",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "executive_summary",
      "function": "summarize",
      "notes": "The slide uses a 2x2 grid layout to summarize key company metrics.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b731-71da-a78f-007719e300bb/3",
      "deckHref": "/decks/019de076-b731-71da-a78f-007719e300bb",
      "deckAnchorHref": "/decks/019de076-b731-71da-a78f-007719e300bb#slide-3",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b731-71da-a78f-007719e300bb",
      "docSlug": "1616e8b22ac58e7f024f1153201d610f",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 4,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a list of four key pillars of the company's methodology.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b731-71da-a78f-007719e300bb/4",
      "deckHref": "/decks/019de076-b731-71da-a78f-007719e300bb",
      "deckAnchorHref": "/decks/019de076-b731-71da-a78f-007719e300bb#slide-4",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 10,
          "from": 4,
          "beatId": "1b4ba678-72a5-41ab-80a1-d0e9467146f7",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The deck presents Nuvalent's approach as a potential solution to the problem.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b731-71da-a78f-007719e300bb",
      "docSlug": "1616e8b22ac58e7f024f1153201d610f",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a chronological structure to demonstrate operational momentum.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b731-71da-a78f-007719e300bb/5",
      "deckHref": "/decks/019de076-b731-71da-a78f-007719e300bb",
      "deckAnchorHref": "/decks/019de076-b731-71da-a78f-007719e300bb#slide-5",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 10,
          "from": 4,
          "beatId": "1b4ba678-72a5-41ab-80a1-d0e9467146f7",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The deck presents Nuvalent's approach as a potential solution to the problem.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b731-71da-a78f-007719e300bb",
      "docSlug": "1616e8b22ac58e7f024f1153201d610f",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "timeline",
      "function": "plan_implementation",
      "notes": "The slide uses a timeline to connect corporate strategy to specific clinical trial milestones.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b731-71da-a78f-007719e300bb/6",
      "deckHref": "/decks/019de076-b731-71da-a78f-007719e300bb",
      "deckAnchorHref": "/decks/019de076-b731-71da-a78f-007719e300bb#slide-6",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 10,
          "from": 4,
          "beatId": "1b4ba678-72a5-41ab-80a1-d0e9467146f7",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The deck presents Nuvalent's approach as a potential solution to the problem.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b731-71da-a78f-007719e300bb",
      "docSlug": "1616e8b22ac58e7f024f1153201d610f",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "team_bio",
      "function": "other",
      "notes": "The slide features a split layout with a left-hand column for advisors/board and a right-hand grid for the leadership team, plus a footer highlighting 12 prior FDA approvals.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b731-71da-a78f-007719e300bb/7",
      "deckHref": "/decks/019de076-b731-71da-a78f-007719e300bb",
      "deckAnchorHref": "/decks/019de076-b731-71da-a78f-007719e300bb#slide-7",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 10,
          "from": 4,
          "beatId": "1b4ba678-72a5-41ab-80a1-d0e9467146f7",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The deck presents Nuvalent's approach as a potential solution to the problem.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        },
        {
          "to": 7,
          "from": 7,
          "beatId": "a00d9936-01d6-4185-a968-19b83acace1b",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Team",
          "beatSlug": "sequoia-pitch-team",
          "evidence": "The deck presents the team's experience and expertise.",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b731-71da-a78f-007719e300bb",
      "docSlug": "1616e8b22ac58e7f024f1153201d610f",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 8,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a Gantt-style visualization to represent drug development stages.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b731-71da-a78f-007719e300bb/8",
      "deckHref": "/decks/019de076-b731-71da-a78f-007719e300bb",
      "deckAnchorHref": "/decks/019de076-b731-71da-a78f-007719e300bb#slide-8",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 10,
          "from": 4,
          "beatId": "1b4ba678-72a5-41ab-80a1-d0e9467146f7",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The deck presents Nuvalent's approach as a potential solution to the problem.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b731-71da-a78f-007719e300bb",
      "docSlug": "1616e8b22ac58e7f024f1153201d610f",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 9,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide uses a structured table to contrast two distinct patient populations (ALK+ vs ROS1+) across three lines of therapy (1L, 2L, 3L+).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b731-71da-a78f-007719e300bb/9",
      "deckHref": "/decks/019de076-b731-71da-a78f-007719e300bb",
      "deckAnchorHref": "/decks/019de076-b731-71da-a78f-007719e300bb#slide-9",
      "loopMatches": [
        {
          "to": 11,
          "from": 9,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "a5fd2686-9365-4f77-a28b-41b78335203d",
          "evidence": "The deck presents the limitations of current treatment options and the potential benefits of Nuvalent's approach.",
          "position": 0,
          "objective": "Highlight the limitations of current treatment options and the need for new solutions",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 9,
          "beatId": "8ce3a4ab-d75c-452e-affd-27d01d209f99",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Problem",
          "beatSlug": "sequoia-pitch-problem",
          "evidence": "The deck presents the problem of emerging resistance mutations, increasing CNS involvement, and treatment-related adverse events.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        },
        {
          "to": 10,
          "from": 4,
          "beatId": "1b4ba678-72a5-41ab-80a1-d0e9467146f7",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The deck presents Nuvalent's approach as a potential solution to the problem.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b731-71da-a78f-007719e300bb",
      "docSlug": "1616e8b22ac58e7f024f1153201d610f",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 10,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Uses a 'cite_precedent' framework to validate the strategy by comparing it to the established success of Osimertinib.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b731-71da-a78f-007719e300bb/10",
      "deckHref": "/decks/019de076-b731-71da-a78f-007719e300bb",
      "deckAnchorHref": "/decks/019de076-b731-71da-a78f-007719e300bb#slide-10",
      "loopMatches": [
        {
          "to": 11,
          "from": 9,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "a5fd2686-9365-4f77-a28b-41b78335203d",
          "evidence": "The deck presents the limitations of current treatment options and the potential benefits of Nuvalent's approach.",
          "position": 0,
          "objective": "Highlight the limitations of current treatment options and the need for new solutions",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 10,
          "from": 4,
          "beatId": "1b4ba678-72a5-41ab-80a1-d0e9467146f7",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "The deck presents Nuvalent's approach as a potential solution to the problem.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b731-71da-a78f-007719e300bb",
      "docSlug": "1616e8b22ac58e7f024f1153201d610f",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": "The chart visualizes the dominance of Alectinib and Crizotinib in the current market landscape.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b731-71da-a78f-007719e300bb/11",
      "deckHref": "/decks/019de076-b731-71da-a78f-007719e300bb",
      "deckAnchorHref": "/decks/019de076-b731-71da-a78f-007719e300bb#slide-11",
      "loopMatches": [
        {
          "to": 11,
          "from": 9,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "a5fd2686-9365-4f77-a28b-41b78335203d",
          "evidence": "The deck presents the limitations of current treatment options and the potential benefits of Nuvalent's approach.",
          "position": 0,
          "objective": "Highlight the limitations of current treatment options and the need for new solutions",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 11,
          "from": 11,
          "beatId": "bbc7ea3f-0c45-4121-8599-5b0e889b8b67",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Market Sizing",
          "beatSlug": "sequoia-pitch-market-size",
          "evidence": "The deck presents the market sizing for Nuvalent's potential products.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b731-71da-a78f-007719e300bb",
      "docSlug": "1616e8b22ac58e7f024f1153201d610f",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "context",
      "function": "establish_context",
      "notes": "Slide 12 of a pitch deck, likely from Nuvalent.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b731-71da-a78f-007719e300bb/12",
      "deckHref": "/decks/019de076-b731-71da-a78f-007719e300bb",
      "deckAnchorHref": "/decks/019de076-b731-71da-a78f-007719e300bb#slide-12",
      "loopMatches": [
        {
          "to": 14,
          "from": 12,
          "name": "Jobs To Be Done",
          "slug": "53-jobs-to-be-done",
          "bestFor": "Product innovation, market entry, competitive positioning",
          "matchId": "7d830543-88bb-4201-aa83-945a257879d6",
          "evidence": "The deck presents the patient journey and how Nuvalent's approach addresses their needs.",
          "position": 1,
          "objective": "Show how Nuvalent's approach addresses the needs of patients with ALK+ NSCLC",
          "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
          "confidence": 0.6,
          "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b731-71da-a78f-007719e300bb",
      "docSlug": "1616e8b22ac58e7f024f1153201d610f",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "customer_journey",
      "function": "frame_problem",
      "notes": "The slide uses a timeline-based journey map to contrast standard treatments with unmet clinical needs.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b731-71da-a78f-007719e300bb/13",
      "deckHref": "/decks/019de076-b731-71da-a78f-007719e300bb",
      "deckAnchorHref": "/decks/019de076-b731-71da-a78f-007719e300bb#slide-13",
      "loopMatches": [
        {
          "to": 14,
          "from": 12,
          "name": "Jobs To Be Done",
          "slug": "53-jobs-to-be-done",
          "bestFor": "Product innovation, market entry, competitive positioning",
          "matchId": "7d830543-88bb-4201-aa83-945a257879d6",
          "evidence": "The deck presents the patient journey and how Nuvalent's approach addresses their needs.",
          "position": 1,
          "objective": "Show how Nuvalent's approach addresses the needs of patients with ALK+ NSCLC",
          "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
          "confidence": 0.6,
          "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b731-71da-a78f-007719e300bb",
      "docSlug": "1616e8b22ac58e7f024f1153201d610f",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide uses a matrix-style comparison to highlight the superior/differentiated profile of the 4th generation inhibitor NVL-655.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b731-71da-a78f-007719e300bb/14",
      "deckHref": "/decks/019de076-b731-71da-a78f-007719e300bb",
      "deckAnchorHref": "/decks/019de076-b731-71da-a78f-007719e300bb#slide-14",
      "loopMatches": [
        {
          "to": 14,
          "from": 12,
          "name": "Jobs To Be Done",
          "slug": "53-jobs-to-be-done",
          "bestFor": "Product innovation, market entry, competitive positioning",
          "matchId": "7d830543-88bb-4201-aa83-945a257879d6",
          "evidence": "The deck presents the patient journey and how Nuvalent's approach addresses their needs.",
          "position": 1,
          "objective": "Show how Nuvalent's approach addresses the needs of patients with ALK+ NSCLC",
          "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
          "confidence": 0.6,
          "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b731-71da-a78f-007719e300bb",
      "docSlug": "1616e8b22ac58e7f024f1153201d610f",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide presents two distinct scientific data sets: an IC50 dot plot for in vitro activity and a bar chart for in vivo tumor regression.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b731-71da-a78f-007719e300bb/15",
      "deckHref": "/decks/019de076-b731-71da-a78f-007719e300bb",
      "deckAnchorHref": "/decks/019de076-b731-71da-a78f-007719e300bb#slide-15",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b731-71da-a78f-007719e300bb",
      "docSlug": "1616e8b22ac58e7f024f1153201d610f",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Includes a formula for Selectivity index and a legend for various compound mutations.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b731-71da-a78f-007719e300bb/16",
      "deckHref": "/decks/019de076-b731-71da-a78f-007719e300bb",
      "deckAnchorHref": "/decks/019de076-b731-71da-a78f-007719e300bb#slide-16",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b731-71da-a78f-007719e300bb",
      "docSlug": "1616e8b22ac58e7f024f1153201d610f",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The slide provides a detailed breakdown of patient enrollment across different dose cohorts (15mg to 200mg QD) for the NVL-655 clinical trial.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b731-71da-a78f-007719e300bb/17",
      "deckHref": "/decks/019de076-b731-71da-a78f-007719e300bb",
      "deckAnchorHref": "/decks/019de076-b731-71da-a78f-007719e300bb#slide-17",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b731-71da-a78f-007719e300bb",
      "docSlug": "1616e8b22ac58e7f024f1153201d610f",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Data cut-off: 8 Aug 2023. Includes detailed breakdown of prior ALK TKI therapies.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b731-71da-a78f-007719e300bb/18",
      "deckHref": "/decks/019de076-b731-71da-a78f-007719e300bb",
      "deckAnchorHref": "/decks/019de076-b731-71da-a78f-007719e300bb#slide-18",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b731-71da-a78f-007719e300bb",
      "docSlug": "1616e8b22ac58e7f024f1153201d610f",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 19,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Slide presents two distinct clinical data visualizations: a PK line chart and a waterfall plot for mutation clearance.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b731-71da-a78f-007719e300bb/19",
      "deckHref": "/decks/019de076-b731-71da-a78f-007719e300bb",
      "deckAnchorHref": "/decks/019de076-b731-71da-a78f-007719e300bb#slide-19",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b731-71da-a78f-007719e300bb",
      "docSlug": "1616e8b22ac58e7f024f1153201d610f",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 20,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Data cut-off: 8 Aug 2023. Includes detailed breakdown of response by mutation type and prior treatment history.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b731-71da-a78f-007719e300bb/20",
      "deckHref": "/decks/019de076-b731-71da-a78f-007719e300bb",
      "deckAnchorHref": "/decks/019de076-b731-71da-a78f-007719e300bb#slide-20",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b731-71da-a78f-007719e300bb",
      "docSlug": "1616e8b22ac58e7f024f1153201d610f",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 21,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Clinical trial data (ALKove-1) showing efficacy of NVL-655 in NSCLC patients.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b731-71da-a78f-007719e300bb/21",
      "deckHref": "/decks/019de076-b731-71da-a78f-007719e300bb",
      "deckAnchorHref": "/decks/019de076-b731-71da-a78f-007719e300bb#slide-21",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b731-71da-a78f-007719e300bb",
      "docSlug": "1616e8b22ac58e7f024f1153201d610f",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 22,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Swimmer plot visualization of clinical trial patient outcomes.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b731-71da-a78f-007719e300bb/22",
      "deckHref": "/decks/019de076-b731-71da-a78f-007719e300bb",
      "deckAnchorHref": "/decks/019de076-b731-71da-a78f-007719e300bb#slide-22",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b731-71da-a78f-007719e300bb",
      "docSlug": "1616e8b22ac58e7f024f1153201d610f",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 23,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes before/after MRI scans for two specific patient cases.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b731-71da-a78f-007719e300bb/23",
      "deckHref": "/decks/019de076-b731-71da-a78f-007719e300bb",
      "deckAnchorHref": "/decks/019de076-b731-71da-a78f-007719e300bb#slide-23",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b731-71da-a78f-007719e300bb",
      "docSlug": "1616e8b22ac58e7f024f1153201d610f",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 24,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Data cut-off: 8 Aug 2023. N=93 treated patients.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b731-71da-a78f-007719e300bb/24",
      "deckHref": "/decks/019de076-b731-71da-a78f-007719e300bb",
      "deckAnchorHref": "/decks/019de076-b731-71da-a78f-007719e300bb#slide-24",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b731-71da-a78f-007719e300bb",
      "docSlug": "1616e8b22ac58e7f024f1153201d610f",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 25,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a three-column layout to segment the market by treatment line (3L+, 2L, 1L) and contrast current standards of care with the proposed solution's benefits.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b731-71da-a78f-007719e300bb/25",
      "deckHref": "/decks/019de076-b731-71da-a78f-007719e300bb",
      "deckAnchorHref": "/decks/019de076-b731-71da-a78f-007719e300bb#slide-25",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b731-71da-a78f-007719e300bb",
      "docSlug": "1616e8b22ac58e7f024f1153201d610f",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 26,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide outlines a clinical trial design with specific patient cohorts (2a-2d) and study objectives.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b731-71da-a78f-007719e300bb/26",
      "deckHref": "/decks/019de076-b731-71da-a78f-007719e300bb",
      "deckAnchorHref": "/decks/019de076-b731-71da-a78f-007719e300bb#slide-26",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b731-71da-a78f-007719e300bb",
      "docSlug": "1616e8b22ac58e7f024f1153201d610f",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 27,
      "slideType": "context",
      "function": "establish_context",
      "notes": "The slide uses a sidebar 'AT A GLANCE' to summarize key program attributes.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b731-71da-a78f-007719e300bb/27",
      "deckHref": "/decks/019de076-b731-71da-a78f-007719e300bb",
      "deckAnchorHref": "/decks/019de076-b731-71da-a78f-007719e300bb#slide-27",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b731-71da-a78f-007719e300bb",
      "docSlug": "1616e8b22ac58e7f024f1153201d610f",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 28,
      "slideType": "customer_journey",
      "function": "present_framework",
      "notes": "The slide uses a timeline-based framework to contrast 1L and 2L+ treatment landscapes and their associated clinical challenges.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b731-71da-a78f-007719e300bb/28",
      "deckHref": "/decks/019de076-b731-71da-a78f-007719e300bb",
      "deckAnchorHref": "/decks/019de076-b731-71da-a78f-007719e300bb#slide-28",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b731-71da-a78f-007719e300bb",
      "docSlug": "1616e8b22ac58e7f024f1153201d610f",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 29,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide uses a matrix-like comparison to highlight the unique value proposition of NVL-520 compared to standard-of-care drugs.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b731-71da-a78f-007719e300bb/29",
      "deckHref": "/decks/019de076-b731-71da-a78f-007719e300bb",
      "deckAnchorHref": "/decks/019de076-b731-71da-a78f-007719e300bb#slide-29",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b731-71da-a78f-007719e300bb",
      "docSlug": "1616e8b22ac58e7f024f1153201d610f",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 30,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Includes specific pharmacological data points for NVL-520 vs competitors like Crizotinib, Entrectinib, Lorlatinib, Taletrectinib, and Repotrectinib.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b731-71da-a78f-007719e300bb/30",
      "deckHref": "/decks/019de076-b731-71da-a78f-007719e300bb",
      "deckAnchorHref": "/decks/019de076-b731-71da-a78f-007719e300bb#slide-30",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b731-71da-a78f-007719e300bb",
      "docSlug": "1616e8b22ac58e7f024f1153201d610f",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 31,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide presents a summary of a clinical trial, including patient eligibility criteria and a breakdown of patient enrollment by dose cohort.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b731-71da-a78f-007719e300bb/31",
      "deckHref": "/decks/019de076-b731-71da-a78f-007719e300bb",
      "deckAnchorHref": "/decks/019de076-b731-71da-a78f-007719e300bb#slide-31",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-b731-71da-a78f-007719e300bb",
      "docSlug": "1616e8b22ac58e7f024f1153201d610f",
      "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
      "authorId": "nuvalent",
      "authorName": "Nuvalent",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-01-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 32,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Data presented in two side-by-side tables summarizing patient characteristics and treatment history.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-b731-71da-a78f-007719e300bb/32",
      "deckHref": "/decks/019de076-b731-71da-a78f-007719e300bb",
      "deckAnchorHref": "/decks/019de076-b731-71da-a78f-007719e300bb#slide-32",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}